|
24 Feb 2010 |
Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
|
|
24 Feb 2010 |
Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial
|
|
23 Feb 2010 |
GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
|
|
22 Feb 2010 |
Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
|
|
22 Feb 2010 |
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
|
|
22 Feb 2010 |
Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease
|
|
19 Feb 2010 |
Sanofi Pasteur’s A(H1N1) Vaccine Humenza Recommended by European Medicines Agency
|
|
19 Feb 2010 |
NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
|
|
18 Feb 2010 |
VIRxSYS Announces at CROI Promising Results from Its HIV Vaccine Study
|
|
18 Feb 2010 |
GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
|
|
17 Feb 2010 |
Immune Targeting Systems (ITS) Ltd. Secures an GBP 8.65 mln Series A Extension to Fund FP-01, Its Synthetic Universal Flu Vaccine Through Phase-II Studies
|
|
17 Feb 2010 |
In Phase III Data Merck's GARDASIL® Was Efficacious Against Anal Disease Caused by HPV 6,11,16, and 18
|
|
12 Feb 2010 |
Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
|
|
11 Feb 2010 |
Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae
|
|
10 Feb 2010 |
Cancer Research UK to Fund Clinical Trial of ADXS11-001 for the Treatment of Head and Neck Cancer
|
|
08 Feb 2010 |
NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
|
|
08 Feb 2010 |
Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
|
|
08 Feb 2010 |
Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
|
|
08 Feb 2010 |
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
|
|
08 Feb 2010 |
Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
|
|
02 Feb 2010 |
Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
|
|
01 Feb 2010 |
FIRST TREATMENT TO IMPROVE SURVIVAL IN 20 YEARS NOW AVAILABLE FOR PATIENTS WITH OSTEOSARCOMA (BONE CANCER)
|
|
31 Jan 2010 |
Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines
|
|
28 Jan 2010 |
Vical Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma
|
|
20 Jan 2010 |
New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
|
